Andrew Balo
Chief Tech/Sci/R&D Officer bei DEXCOM, INC.
Vermögen: 11 Mio $ am 31.03.2024
Profil
Herr Andrew K. Balo ist EVP-Clinical Affairs, Regulatory Strategy bei DexCom, Inc. Herr Balo war zuvor als Vice President-Regulatory & Clinical Affairs bei InnerCool Therapies, Inc. beschäftigt, als VP-Quality, Regulatory & Clinical Affairs bei St. Jude Medical LLC und als Vice President-Rgulatory & Clinical Affairs bei Endocardial Solutions, Inc. Seinen Bachelor-Abschluss machte er an der University of Maryland.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
DEXCOM, INC.
0,02% | 10.03.2023 | 81 120 ( 0,02% ) | 11 Mio $ | 31.03.2024 |
Aktive Positionen von Andrew Balo
Unternehmen | Position | Beginn |
---|---|---|
DEXCOM, INC. | Chief Tech/Sci/R&D Officer | 01.02.2002 |
Ehemalige bekannte Positionen von Andrew Balo
Unternehmen | Position | Ende |
---|---|---|
Post-Hypothermia Corp.
Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Post-Hypothermia Corp. develops and provides temperature modulation therapy products for the healthcare industry. It also provides CoolBlue, a surface-based temperature modulation system that consists of a console and a disposable CoolBlue vest with upper thigh pads, which is designed for use in less acute patients or prolonged temperature management clinical settings. The company was founded by John D. Dobak in 1998 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01.02.2002 |
ST JUDE MEDICAL INC | Chief Tech/Sci/R&D Officer | 01.01.1997 |
Endocardial Solutions, Inc.
Endocardial Solutions, Inc. Medical SpecialtiesHealth Technology Endocardial Solutions, Inc. designs, develops and manufactures a minimally invasive diagnostic system that diagnoses within the span of a few heartbeats, arrhythmia, a potentially fatal abnormal heart rhythm. The company's EnSite catheters and clinical workstations produce a high-resolution, real-time, three-dimensional color display of electrical activity in the heart chamber, thus allowing electrophysiologists to locate and diagnose tachycardia in real-time and to determine the course of treatment. It was founded in 1992. The company is located in St. Paul, MN. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Andrew Balo
University of Maryland | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
DEXCOM, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
St. Jude Medical LLC
St. Jude Medical LLC Medical SpecialtiesHealth Technology St. Jude Medical LLC develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The company was founded by Manuel A. Villafana in 1976 and is headquartered in St. Paul, MN. | Health Technology |
Endocardial Solutions, Inc.
Endocardial Solutions, Inc. Medical SpecialtiesHealth Technology Endocardial Solutions, Inc. designs, develops and manufactures a minimally invasive diagnostic system that diagnoses within the span of a few heartbeats, arrhythmia, a potentially fatal abnormal heart rhythm. The company's EnSite catheters and clinical workstations produce a high-resolution, real-time, three-dimensional color display of electrical activity in the heart chamber, thus allowing electrophysiologists to locate and diagnose tachycardia in real-time and to determine the course of treatment. It was founded in 1992. The company is located in St. Paul, MN. | Health Technology |
Post-Hypothermia Corp.
Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Post-Hypothermia Corp. develops and provides temperature modulation therapy products for the healthcare industry. It also provides CoolBlue, a surface-based temperature modulation system that consists of a console and a disposable CoolBlue vest with upper thigh pads, which is designed for use in less acute patients or prolonged temperature management clinical settings. The company was founded by John D. Dobak in 1998 and is headquartered in San Diego, CA. | Health Technology |